Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01547390 · ClinicalTrials.gov registry record · NA
Early Prevention of Preeclampsia Study
A NA study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT01547390 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 104 participants.
The verdict
NCT01547390, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
This is a randomized controlled trial to estimate the efficacy of low dose aspirin for preventing preeclampsia in women identified as high risk. The investigators hypothesize that the risk of preeclampsia in women identified by a first trimester multiparameter predictive model to be at high risk will be significantly reduced by initiating low dose aspirin early in pregnancy.
Interventions
- DRUG placebo
- DRUG Aspirin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2012-03 |
| Est. Completion | 2015-07-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01547390
The ClinicalTrials.gov registry entry for NCT01547390 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01547390 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01547390 about?
NCT01547390 is a clinical study titled "Early Prevention of Preeclampsia Study". This is a randomized controlled trial to estimate the efficacy of low dose aspirin for preventing preeclampsia in women identified as high risk. The investigators hypothesize that the risk of preeclampsia in women identified by a first trimester multiparameter predictive model to be at high risk wil...
What is the current status of trial NCT01547390?
This trial is currently terminated. It is a NA study. The enrollment target is 104 participants. The study started on 2012-03. Estimated completion is 2015-07-20.
What interventions are being tested in trial NCT01547390?
The interventions under investigation include: placebo (DRUG), Aspirin (DRUG).
Who is sponsoring clinical trial NCT01547390?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.